These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33635541)

  • 1. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
    Alagoz O; Lowry KP; Kurian AW; Mandelblatt JS; Ergun MA; Huang H; Lee SJ; Schechter CB; Tosteson ANA; Miglioretti DL; Trentham-Dietz A; Nyante SJ; Kerlikowske K; Sprague BL; Stout NK;
    J Natl Cancer Inst; 2021 Nov; 113(11):1484-1494. PubMed ID: 34258611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.
    Sprague BL; O'Meara ES; Lee CI; Lee JM; Henderson LM; Buist DSM; Alsheik N; Macarol T; Perry H; Tosteson ANA; Onega T; Kerlikowske K; Miglioretti DL
    Prev Med; 2021 Oct; 151():106540. PubMed ID: 34217424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
    PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 10. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
    Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
    CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
    Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
    Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
    Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
    Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of facility and patient mix factors on recovery of screening and diagnostic mammography volumes following the initial COVID-19 pandemic wave.
    Lomahan S; Rauscher GH; Murphy AM
    Cancer Med; 2023 May; 12(9):10877-10888. PubMed ID: 36924321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of Screening Mammogram Cancellations During COVID-19.
    Pairawan SS; Olmedo Temich L; de Armas S; Folkerts A; Solomon N; Cora C; Ramalingam K; Lum SS
    Am Surg; 2021 Dec; 87(10):1651-1655. PubMed ID: 34628958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding mechanisms of racial disparities in breast cancer: an assessment of screening and regular care in the Carolina Breast Cancer Study.
    Dunn MR; Metwally EM; Vohra S; Hyslop T; Henderson LM; Reeder-Hayes K; Thompson CA; Lafata JE; Troester MA; Butler EN
    Cancer Causes Control; 2024 May; 35(5):825-837. PubMed ID: 38217760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
    Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Breast Cancer Screening Adherence During the COVID-19 Pandemic in a Cohort at Increased Inherited Cancer Risk in the United States.
    Harris A; Bather JR; Kawamoto K; Fiol GD; Bradshaw RL; Kaiser-Jackson L; Monahan R; Kohlmann W; Liu F; Ginsburg O; Goodman MS; Kaphingst KA
    Cancer Control; 2024; 31():10732748241272727. PubMed ID: 39420801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.